← Back to guidelines
Cardiology13 papers

Poikiloderma with neutropenia

Last edited: 4/22/2026

Overview

Poikiloderma with neutropenia encompasses acquired poikiloderma, characterized by cutaneous atrophy, telangiectasia, and pigmentary changes, often with associated neutropenia. This condition has multiple etiologies including phototoxic reactions, hormonal changes, and contact sensitization 13.

Diagnosis

  • Clinical Presentation: Mottled skin appearance with atrophy, telangiectasia, and pigmentary changes 1.
  • Differentiating Features:
  • - Poikiloderma of Civatte: Common in menopausal females, typically affects neck and chest 13. - Contact Sensitization: Patch testing with standard and fragrance series may identify allergens like nickel sulfate 3.
  • Photosensitivity Testing: Photopatch testing and photo-testing with monochromators can assess photosensitivity 3.
  • Management

  • First-Line Treatments:
  • - Intense Pulsed Light (IPL) Therapy: Effective for treating vascular and pigmented components, with high clearance rates (>80%) and minimal side effects 2.
  • Adjunctive Treatments:
  • - Photoprotection: Use of broad-spectrum sunscreens and protective clothing to prevent further photodamage 1. - Topical Agents: Specific agents not detailed in abstracts, but may include retinoids or antioxidants for skin repair 1.

    Special Populations

  • Menopausal Females: Poikiloderma of Civatte predominantly affects this group, emphasizing hormonal influences 13.
  • No Specific Guidance: Limited data on pediatrics, pregnancy, or elderly populations 123.
  • Key Recommendations

  • Utilize IPL Therapy for Treatment: Consider IPL as a safe and effective treatment option for poikiloderma of Civatte, achieving significant clearance rates 2 (Evidence: Strong).
  • Perform Patch and Photopatch Testing: Evaluate contact sensitization and photosensitivity through patch testing and photopatch testing to identify contributing factors 3 (Evidence: Moderate).
  • Implement Photoprotection Measures: Advise patients on the use of photoprotection to prevent exacerbation of symptoms 1 (Evidence: Expert opinion).
  • References

    1 Nofal A, Salah E. Acquired poikiloderma: proposed classification and diagnostic approach. Journal of the American Academy of Dermatology 2013. link 2 Rusciani A, Motta A, Fino P, Menichini G. Treatment of poikiloderma of Civatte using intense pulsed light source: 7 years of experience. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2008. link 3 Katoulis AC, Stavrianeas NG, Katsarou A, Antoniou C, Georgala S, Rigopoulos D et al.. Evaluation of the role of contact sensitization and photosensitivity in the pathogenesis of poikiloderma of Civatte. The British journal of dermatology 2002. link

    Original source

    1. [1]
      Acquired poikiloderma: proposed classification and diagnostic approach.Nofal A, Salah E Journal of the American Academy of Dermatology (2013)
    2. [2]
      Treatment of poikiloderma of Civatte using intense pulsed light source: 7 years of experience.Rusciani A, Motta A, Fino P, Menichini G Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2008)
    3. [3]
      Evaluation of the role of contact sensitization and photosensitivity in the pathogenesis of poikiloderma of Civatte.Katoulis AC, Stavrianeas NG, Katsarou A, Antoniou C, Georgala S, Rigopoulos D et al. The British journal of dermatology (2002)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG